Vimarsana
Biggest News Aggregation in the World

Metabolism Unit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Metabolism Unit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Metabolism Unit Today - Breaking & Trending Today

Lomitapide Shows Promise in Pediatric Homozygous FH - Vimarsana News

Lomitapide Shows Promise in Pediatric Homozygous FH

Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.

Psilocybin therapy for treatment-resistant depression - Vimarsana News

Psilocybin therapy for treatment-resistant depression

Guy Goodwin of COMPASS Pathways, explores the potential of tryptamines / psilocybin therapy in treatment resistant depression.

Navidea Biopharmaceuticals Reports Second Quarter 2022 Financial Results - Vimarsana News

Navidea Biopharmaceuticals Reports Second Quarter 2022 Financial Results

15.08.2022 - Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the second quarter and ...

COVID-19 Vaccinations in People With HIV Match Community Rates - Vimarsana News

COVID-19 Vaccinations in People With HIV Match Community Rates

The first study of its kind shows regional global disparities in COVID-19 vaccination rates among people with HIV, who are at higher risk for COVID-19 mortality.

New insights about COVID-19 vaccination rates among people living with HIV - Vimarsana News

New insights about COVID-19 vaccination rates among people living with HIV

The AIDS Clinical Trials Group, the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that insights around COVID-19 vaccination rates among people living with HV have been published in the Journal of Infectious Diseases.